Intraoperative intrapleural hypotonic cisplatin treatment for carcinomatous pleuritis

Journal of Surgical Oncology

Volumn 66, Issue 3, 1997, Pages 196-200

  Ichinose, Yukito ^a   Yano, Tokujiro ^a   Asoh, Hiroshi ^a   Yokoyama, Hideki ^a   Fukuyama, Yasuro ^a   Miyagi, Jun ^a   Kuninaka, Shinji ^a   Terazaki, Yasuhiro ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

Carcinomatous pleuritis; Cisplatin; Intracavitary chemotherapy; Malignant effusion; Non small cell lung cancer

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; INTRAPLEURAL DRUG ADMINISTRATION; MALE; PLEURA CANCER; PLEURISY; PRIORITY JOURNAL; THORACOTOMY;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; FEMALE; HUMANS; HYPOTONIC SOLUTIONS; INTRAOPERATIVE CARE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLATINUM; PLEURAL EFFUSION, MALIGNANT; PLEURISY; RETROSPECTIVE STUDIES; SURVIVAL RATE; THORACOTOMY;

EID: 0030712421     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199711)66:3<196::AID-JSO8>3.0.CO;2-7     Document Type: Article

References (13)

1. Ichinose Y, Hara N, Ohta M, Yano T, Maeda K, Hata K: Survival of patients with non-small cell lung cancer undergoing incomplete resection or exploratory thoracotomy with no resection. Lung Cancer 1993;8:265-274.
2. Ichinose Y, Hara N, Ohta M, et al.: Hypotonic cisplatin treatment for carcinomatous pleuritis found at thoracotomy in patients with lung cancer. J Thorac Cardiovasc Surg 1993;105:1041-1046.
3. LeRoy AF, Wehling ML, Sponseller HL, et al.: Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry. Biochem Med 1977;18:184-191.
4. Gibaldi M, Perrier D (eds): "Pharmacokinetics." 2nd ed. New York: Dekker, 1982.
5. Walker-Renard PB, Vaughan LM, Sahn SA: Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 1994;120:56-64.
6. Yim APC, Chan ATC, Lee TW, Baker TR, Emrich LJ, Hartman AB: Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann Thorac Surg 1996;62:1655-1658.
7. Piver MS, Lele SB, Marchetti DL, Wan IYP, Ho JKS: Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma. J Clin Oncol 1988;6:1679-1684.
8. Reichman B, Markman M, Hakes T, et al.: Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinoma. J Clin Oncol 1989;7:1327-1332.
9. Rusch VW, Figlin R, Godwin D, Piantadosi S: Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: A lung cancer study group trial. J Clin Oncol 1991;9: 313-319.
10. Rosenberg B: Platinum complex-DNA interactions and anticancer activity. Biochimie 1978;60:859-867.
11. Sherman SE, Lippard SJ: Structural aspects of platinum anticancer drug interactions with DNA. Chem Rev 1987;87:1153-1181.
12. Rusch VW, Niedzwiecki D, Tao Y, et al.: Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleuroectomy: Pharmacokinetic studies. J Clin Oncol 1992;10:1001-1006.
13. Yasumoto K, Shimokawa T, Nagashima A, Hirose N, Nakahashi H: Pharmacokinetics of cisplatin instilled into the pleural cavity following panpleuropneumonectomy in patients with malignant pleurisy due to lung cancer. J Surg Oncol 1993;54:67-70.